Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Reba

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
The American Journal of Cardiology|March 1, 1989
Clinical and hemodynamic significance of left ventricular diastolic volume changes by exercise radionuclide ventriculography in coronary artery diseaseB W Choi, A G Wasserman, R J Katz, et al.
The American Journal of Cardiology|December 1, 1982
Noninvasive detection of multivessel disease after myocardial infarction by exercise radionuclide ventriculographyA G Wasserman, R J Katz, P Cleary, et al.
Clinical Chemistry|March 1, 1982
Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomasP C Pieslor, R E Gibson, W C Eckelman, et al.
Neuroimage|February 1, 1996
Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtypeS F Boulay, V K Sood, M R Rayeq, et al.
Life Sciences|June 4, 1984
[125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptorsR E Gibson, W J Rzeszotarski, E M Jagoda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Three-dimensional SPECT simulations of a complex three-dimensional mathematical brain model and measurements of the three-dimensional physical brain phantomH J Kim, B R Zeeberg, F H Fahey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1974
The toxicity of Sn-pyrophosphate: clinical manifestations prior to acute LD50J S Stevenson, W C Eckelman, P Z Sobocinski, et al.
Biochemical Pharmacology|June 15, 1983
Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptorsR E Gibson, W J Rzeszotarski, W C Eckelman, et al.
Receptor|January 1, 1995
Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype compositionS F Boulay, M S Gitler, V K Sood, et al.
Nuclear Medicine and Biology|April 1, 1996
Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivoS F Boulay, R C McRee, V I Cohen, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
The American Journal of Cardiology|March 1, 1989
Clinical and hemodynamic significance of left ventricular diastolic volume changes by exercise radionuclide ventriculography in coronary artery diseaseB W Choi, A G Wasserman, R J Katz, et al.
The American Journal of Cardiology|December 1, 1982
Noninvasive detection of multivessel disease after myocardial infarction by exercise radionuclide ventriculographyA G Wasserman, R J Katz, P Cleary, et al.
Clinical Chemistry|March 1, 1982
Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomasP C Pieslor, R E Gibson, W C Eckelman, et al.
Neuroimage|February 1, 1996
Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtypeS F Boulay, V K Sood, M R Rayeq, et al.
Life Sciences|June 4, 1984
[125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptorsR E Gibson, W J Rzeszotarski, E M Jagoda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1991
Three-dimensional SPECT simulations of a complex three-dimensional mathematical brain model and measurements of the three-dimensional physical brain phantomH J Kim, B R Zeeberg, F H Fahey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1974
The toxicity of Sn-pyrophosphate: clinical manifestations prior to acute LD50J S Stevenson, W C Eckelman, P Z Sobocinski, et al.
Biochemical Pharmacology|June 15, 1983
Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptorsR E Gibson, W J Rzeszotarski, W C Eckelman, et al.
Receptor|January 1, 1995
Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype compositionS F Boulay, M S Gitler, V K Sood, et al.
Nuclear Medicine and Biology|April 1, 1996
Specific binding component of the "inactive" stereoisomer (S,S)-[125I] IQNB to rat brain muscarinic receptors in vivoS F Boulay, R C McRee, V I Cohen, et al.
Pageof 17